top of page
We are a Cannabis CPG Company focused on the European market.
Europe has historically been the home of cannabis tastemakers through some of the world's most respected genetics and breeders. Now we about to see a resurgence on the back of more appropriate regulatory frameworks and a growing mainstream acceptance beyond traditional cannabis culture.
The European industry has to date been focused on the production and distribution of medical cannabis - leaving customer-centric CPG largely underdeveloped due to a wellness market limited to CBD and no adult use opportunities. That’s about to start changing fast and the commercial opportunity is already huge. An adult use market of €1.5 billion by 2026.
Our strategic approach is nimble and dynamic - set up to enter markets as the opportunities present themselves.
Our first product (CBD Vape) will launch in the UK market in 2023, expanding into THC as different jurisdictions open up.
We will leverage the Palm House platform to capture significant market share across Europe, launching new products, brands, geographies and distribution channels over time.
We are a founding team with a proven track record in both global cannabis and also working with some of the world's leading consumer brands. We have built cannabis companies in the UK, Canada, Germany and the USA - collectively raising over €100m with multiple public and trade exits.
bottom of page